+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Animal Specialty Drugs Market 2021-2025

  • ID: 5145589
  • Report
  • July 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Bayer AG
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Henry Schein Inc.
  • Merck and Co. Inc.
  • Vetoquinol SA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the companion animal specialty drugs market and it is poised to grow by USD 2.80 bn during 2021-2025, progressing at a CAGR of 5.20% during the forecast period. The report on the companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.



The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rise in aging companion animal population.



The companion animal specialty drugs market analysis includes the product segment and geographic landscape.



The companion animal specialty drugs market is segmented as below:


By Product

  • Vaccines
  • Antibiotics
  • Parasiticides
  • Feed additives
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the enhanced product offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, increase in M&A and rising obesity in pets will lead to sizable demand in the market.



The report on companion animal specialty drugs market covers the following areas:

  • Companion animal specialty drugs market sizing
  • Companion animal specialty drugs market forecast
  • Companion animal specialty drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal specialty drugs market vendors that include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Henry Schein Inc., Merck and Co. Inc., Vetoquinol SA, Virbac, and Zoetis Inc. Also, the companion animal specialty drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.



The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.



The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Henry Schein Inc.
  • Merck and Co. Inc.
  • Vetoquinol SA

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Vaccines - Market size and forecast 2020-2025
  • Antibiotics - Market size and forecast 2020-2025
  • Parasiticides - Market size and forecast 2020-2025
  • Feed additives - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Henry Schein Inc.
  • Merck and Co. Inc.
  • Vetoquinol SA
  • Virbac
  • Zoetis Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Vaccines - Market size and forecast 2020-2025 ($ million)
  • Vaccines - Year-over-year growth 2020-2025 (%)
  • Antibiotics - Market size and forecast 2020-2025 ($ million)
  • Antibiotics - Year-over-year growth 2020-2025 (%)
  • Parasiticides - Market size and forecast 2020-2025 ($ million)
  • Parasiticides - Year-over-year growth 2020-2025 (%)
  • Feed additives - Market size and forecast 2020-2025 ($ million)
  • Feed additives - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ million)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Business segments
  • Boehringer Ingelheim International GmbH - Key offerings
  • Boehringer Ingelheim International GmbH - Key customers
  • Boehringer Ingelheim International GmbH - Segment focus
  • Ceva Sante Animale - Overview
  • Ceva Sante Animale - Product and service
  • Ceva Sante Animale - Key offerings
  • Ceva Sante Animale - Key customers
  • Ceva Sante Animale - Segment focus
  • Dechra Pharmaceuticals Plc - Overview
  • Dechra Pharmaceuticals Plc - Product and service
  • Dechra Pharmaceuticals Plc - Key offerings
  • Dechra Pharmaceuticals Plc - Key customers
  • Dechra Pharmaceuticals Plc - Segment focus
  • Elanco Animal Health Inc. - Overview
  • Elanco Animal Health Inc. - Product and service
  • Elanco Animal Health Inc. - Key offerings
  • Elanco Animal Health Inc. - Key customers
  • Elanco Animal Health Inc. - Segment focus
  • Henry Schein Inc. - Overview
  • Henry Schein Inc. - Business segments
  • Henry Schein Inc. - Key offerings
  • Henry Schein Inc. - Key customers
  • Henry Schein Inc. - Segment focus
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Key customers
  • Merck and Co. Inc. - Segment focus
  • Vetoquinol SA - Overview
  • Vetoquinol SA - Business segments
  • Vetoquinol SA - Key offerings
  • Vetoquinol SA - Key customers
  • Vetoquinol SA - Segment focus
  • Virbac - Overview
  • Virbac - Business segments
  • Virbac - Key offerings
  • Virbac - Key customers
  • Virbac - Segment focus
  • Zoetis Inc. - Overview
  • Zoetis Inc. - Business segments
  • Zoetis Inc. - Key offerings
  • Zoetis Inc. - Key customers
  • Zoetis Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Henry Schein Inc.
  • Merck and Co. Inc.
  • Vetoquinol SA
The publisher recognizes the following companies as the key players in the global companion animal specialty drugs market: Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Henry Schein Inc., Merck and Co. Inc., Vetoquinol SA, Virbac, and Zoetis Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is enhanced product offerings.`

According to the report, one of the major drivers for this market is the increase in pet humanization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Henry Schein Inc.
  • Merck and Co. Inc.
  • Vetoquinol SA
  • Virbac
  • Zoetis Inc.
Note: Product cover images may vary from those shown